The aim of the present study was to evaluate the effects of
L-arginine-HCl supplementation on ovulation rate, fertility, prolificacy, and serum
VEGF concentrations in ewes with synchronized oestrus. Thirty Suffolk ewes with a mean
body weight of 45 ± 3 kg and a mean body condition score (BCS) of 2.4 ± 0.28 were synchronized for estrus presentation with a
progestin-containing sponge (20 mg Chronogest® CR) for 9 days plus PGF2-α (
Lutalyse; Pfizer, USA) on day 7 after the insertion of the sponge. The ewes were divided into two groups; i.e., a control group (n = 15) that was fed on the native pasture (basal diet) and an
L-arginine-HCl group (n = 15) that received 7.8 g of rumen-protected
L-arginine-HCl from day 5 of the sponge insertion until day 25 after mating plus the basal diet. The
L-arginine-HCl was administered daily via an esophageal probe between days 5 and 9 of the synchronization protocol and every third day subsequently. Blood samples were drawn from the jugular vein every 6 days throughout the entire experimental period. The results revealed that the
L-arginine-HCl supplementation increased fertility during the synchronized estrus (P = 0.05). However, no effects were observed on the final BCS (P = 0.78), estrus presentation (P = 0.33), multiple ovulations (P = 0.24), prolificacy (P = 0.63), or serum
VEGF concentration. In conclusion,
L-arginine-HCl supplementation during the period used in this study increased fertility in sheep with synchronized estrus possibly due to improved embryo-fetal survival during early pregnancy.